We are live on ! Find out more
DRTX

DURATA THERAPEUTICS INC COM STK (DE)
DRTX

Delisted

DRTX was delisted on the 17th of November, 2014.

46 hedge funds and large institutions have $164M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more capital invested

Capital invested by funds: $65.8M → $164M (+$97.9M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

14% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 14

4% less funds holding

Funds holding: 4846 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
6
Increased
16
Reduced
14
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aisling Capital
New York
$40M +$32.8M +3,130,824 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$28.3M +$13M +1,236,510 +127%
CPV
3
Canaan Partners VII
Connecticut
$24.3M +$20M +1,902,030 New
O
4
OrbiMed
New York
$22.8M
DCM
5
Discovery Capital Management
Connecticut
$15.2M
BFA
6
BlackRock Fund Advisors
California
$4.54M -$168K -16,063 -4%
Millennium Management
7
Millennium Management
New York
$3.33M +$841K +80,153 +44%
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.3M +$27K +2,575 +1%
BC
9
Broadfin Capital
New York
$2.41M -$2.04M -194,521 -51%
Northern Trust
10
Northern Trust
Illinois
$2.34M +$63.3K +6,031 +3%
State Street
11
State Street
Massachusetts
$2.29M +$386K +36,844 +26%
MSA
12
Mason Street Advisors
Wisconsin
$1.77M +$1.46M +138,790 New
EI
13
EAM Investors
California
$1.59M +$1.31M +124,691 New
BIT
14
BlackRock Institutional Trust
California
$1.55M -$182K -17,336 -13%
BCM
15
Bridgeway Capital Management
Texas
$974K
TAM
16
Tocqueville Asset Management
New York
$921K -$43K -4,100 -5%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$814K +$158K +15,043 +31%
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$725K +$100K +9,563 +20%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$709K +$42.4K +4,042 +8%
TCIM
20
TIAA CREF Investment Management
New York
$671K
Alyeska Investment Group
21
Alyeska Investment Group
Illinois
$640K -$524K -50,000 -50%
JP Morgan Chase
22
JP Morgan Chase
New York
$603K +$9.28K +885 +2%
Bank of America
23
Bank of America
North Carolina
$525K -$57.6K -5,491 -12%
NFA
24
Nationwide Fund Advisors
Ohio
$512K +$310K +29,561 +282%
BIM
25
BlackRock Investment Management
Delaware
$457K -$13.4K -1,282 -3%

DRTX Hedge Fund Activity: Q4 2013 in Review

46 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q4 2013, worth a combined $164M — up 149% from $65.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of DRTX and 6 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 16 added.

The largest buyer was Wellington Management Group, adding an estimated $13M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.6M sold.

  • 46 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q4 2013, down from 48 in Q3 2013.
  • Funds reported $164M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q4 2013, up 149% quarter-over-quarter.
  • 6 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q4 2013 and 8 closed out, a net change of -2 holders.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q4 2013 was Wellington Management Group, an estimated $13M added.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q4 2013 was Great Point Partners, an estimated $4.6M sold.

Based on aggregated 13F filings for Q4 2013.